Key facts
- Svastek’s last known valuation is $850K (Jan 2025).
- It has raised $230K.
- Notable investors include Chitkara University, Golden Jubilee Biotech Park, IAN Fund, Startup Punjab.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Svastek
- ·The full record, as it builds
Funding rounds
No funding rounds for Svastek are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Svastek
Provider of healthcare technology services intended to empower patient care by addressing critical gaps in existing medical technologies. The company offers the ALLTIP Technology-enabled NIV mask, a non-invasive ventilation product that allows simultaneous nutrition delivery, improving clinical outcomes and reducing malnutrition-related risks in patients on long-term respiratory support, enabling clients with services to tackle global issues in medical technology.
- Sector
- Healthcare
- HQ
- New Delhi, India
- Founded
- 2022
- Employees
- 5
- Website
- svastek.com/
- Ownership
- Privately Held (backing)
Svastek doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Svastek shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Svastek in its N-PORT filings yet. We sweep new filings monthly.